Cargando…

Clinical characteristics of hematological patients concomitant with COVID‐19

The rapid spread of coronavirus disease 2019 (COVID‐19) represented the most serious issue to public health globally. Hematological patients as immunocompromised hosts are vulnerable to severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection. There is little information available rega...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Xiaoxi, Wang, Gaoxiang, Chen, Liting, Meng, Fankai, Huang, Liang, Huang, Lifang, Wang, Na, Li, Tongjuan, Cao, Yang, Zhou, Jianfeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7361643/ https://www.ncbi.nlm.nih.gov/pubmed/32619034 http://dx.doi.org/10.1111/cas.14544

Ejemplares similares

Dynamics of Blood Viral Load Is Strongly Associated with Clinical Outcomes in Coronavirus Disease 2019 (COVID-19) Patients: A Prospective Cohort Study
por: Chen, Liting, et al.
Publicado: (2021)

Ruxolitinib in treatment of severe coronavirus disease 2019 (COVID-19): A multicenter, single-blind, randomized controlled trial
por: Cao, Yang, et al.
Publicado: (2020)

Elevated serum levels of S100A8/A9 and HMGB1 at hospital admission are correlated with inferior clinical outcomes in COVID-19 patients
por: Chen, Liting, et al.
Publicado: (2020)

CAR T-Cell Therapy Is Effective but Not Long-Lasting in B-Cell Lymphoma of the Brain
por: Li, Tongjuan, et al.
Publicado: (2020)

Sequential CD19/22 CAR T-cell immunotherapy following autologous stem cell transplantation for central nervous system lymphoma
por: Wu, Jiaying, et al.
Publicado: (2021)

Case report: simultaneous occurrence of multiple myeloma and non-Hodgkin lymphoma treated by CAR T therapy
por: Li, Tongjuan, et al.
Publicado: (2020)

Clinical characteristics of moderate and severe cases with COVID-19 in Wuhan, China: a retrospective study
por: Sheng, Lingshuang, et al.
Publicado: (2020)

Clinical characteristics and prognosis of 16 relapsed/refractory B-cell malignancy patients with CAR T-cell-related hyperferritinaemia
por: Zhou, Lanlan, et al.
Publicado: (2022)

Chimeric Antigen Receptor-Modified T Cell Immunotherapy for Relapsed and Refractory Adult Burkitt Lymphoma
por: Wu, Jiaying, et al.
Publicado: (2022)

TALENs-mediated gene disruption of FLT3 in leukemia cells: Using genome-editing approach for exploring the molecular basis of gene abnormality
por: Wang, Jue, et al.
Publicado: (2015)

A good response of refractory mantel cell lymphoma to haploidentical CAR T cell therapy after failure of autologous CAR T cell therapy
por: Li, Tongjuan, et al.
Publicado: (2019)

MIP3α as an early prognostic predictor for patients with B-cell malignancies receiving CD19/CD22-redirected CAR-T cell cocktail therapy
por: Jin, Jin, et al.
Publicado: (2023)

Severe early hepatitis B reactivation in a patient receiving anti-CD19 and anti-CD22 CAR T cells for the treatment of diffuse large B-cell lymphoma
por: Wei, Jia, et al.
Publicado: (2019)

Asymptomatic Subclinical Cases of Coronavirus Disease 2019 without Viral Transmission in Three Independent Families
por: Zhang, Xian, et al.
Publicado: (2020)

Reply
por: Cao, Yang, et al.
Publicado: (2020)

Human MLL-AF9 Overexpression Induces Aberrant Hematopoietic Expansion in Zebrafish
por: Tan, Jiaqi, et al.
Publicado: (2018)

Corrigendum to “Human MLL-AF9 Overexpression Induces Aberrant Hematopoietic Expansion in Zebrafish”
por: Tan, Jiaqi, et al.
Publicado: (2022)

Scoring cytokine storm by the levels of MCP-3 and IL-8 accurately distinguished COVID-19 patients with high mortality
por: Chen, Liting, et al.
Publicado: (2020)

Outcome of aggressive B-cell lymphoma with TP53 alterations administered with CAR T-cell cocktail alone or in combination with ASCT
por: Wei, Jia, et al.
Publicado: (2022)

Germline variants in UNC13D and AP3B1 are enriched in COVID-19 patients experiencing severe cytokine storms
por: Luo, Hui, et al.
Publicado: (2021)

Treatment Outcomes and Prognostic Factors in 66 Patients with Chronic Myelomonocytic Leukemia (CMML) in a Single Center
por: Wang, Chao, et al.
Publicado: (2022)

Combined inhibition of Notch and FLT3 produces synergistic cytotoxic effects in FLT3/ITD(+) acute myeloid leukemia
por: Li, Dan, et al.
Publicado: (2020)

SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity
por: Wei, Jia, et al.
Publicado: (2020)

Case Report: Fatal cytomegalovirus pneumonia after CAR-T cell therapy in the long-term follow-up
por: Cheng, Jiali, et al.
Publicado: (2023)

Impact of Opioid Use in Hematological Malignancies: Clinical, Immunological and Concomitant Aspects
por: Tregubenko, Polina, et al.
Publicado: (2020)

Single-cell transcriptomes of peripheral blood cells indicate and elucidate severity of COVID-19
por: Xie, Xiaowei, et al.
Publicado: (2021)

Sequential CAR T-Cell Therapy After Autologous Stem Cell Transplantation for the Treatment of Relapsed/Refractory Intravascular Large B-Cell Lymphoma With Central Nervous System Involvement: A Case Report
por: Liu, Wanying, et al.
Publicado: (2022)

Extracellular Vesicles Expressing CD19 Antigen Improve Expansion and Efficacy of CD19-Targeted CAR-T Cells
por: Zhang, Yuanyuan, et al.
Publicado: (2023)

Therapeutic Use of Convalescent Plasma in COVID-19 Infected Patients with Concomitant Hematological Disorders
por: Lanza, Francesco, et al.
Publicado: (2021)

Case Report: Successful Chimeric Antigen Receptor T Cell Therapy in Haploidentical-Allogeneic Stem Cell Transplant Patients With Post-Transplant Lymphoproliferative Disorder
por: Yan, Nan, et al.
Publicado: (2021)

Identification of Significant Pathways Induced by PAX5 Haploinsufficiency Based on Protein-Protein Interaction Networks and Cluster Analysis in Raji Cell Line
por: Gu, Jia, et al.
Publicado: (2017)

In vitro effects of imatinib on CD34(+) cells of patients with chronic myeloid leukemia in the megakaryocytic crisis phase
por: MENG, FANKAI, et al.
Publicado: (2014)

Clinical Characteristics and Outcomes of COVID-19 in Turkish Patients with Hematological Malignancies
por: Civriz Bozdağ, Sinem, et al.
Publicado: (2022)

Differences in the Clinical and Hematological Characteristics of COVID-19 Patients with and without Type 2 Diabetes
por: Sun, Yujing, et al.
Publicado: (2020)

The functions and clinical significance of circRNAs in hematological malignancies
por: Zhou, Xiangxiang, et al.
Publicado: (2020)

Acute myocardial infarction and concomitant acute intracranial hemorrhage: clinical characteristics and outcomes
por: Cao, Xiangqi, et al.
Publicado: (2022)

Ling-Gui-Zhu-Gan Decoction Protects H9c2 Cells against H(2)O(2)-Induced Oxidative Injury via Regulation of the Nrf2/Keap1/HO-1 Signaling Pathway
por: Wang, Xiang, et al.
Publicado: (2020)

The Clinical Characteristics of ARDS in Children With Hematological Neoplasms
por: Zhang, Qiao, et al.
Publicado: (2021)

COVID-19 in Adult Patients with Hematological Disease: Analysis of Clinical Characteristics and Outcomes
por: Lattenist, R., et al.
Publicado: (2020)

Clinical characteristics of patients with COVID-19 in Huangshi, China
por: Zhang, Xiwen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5pk5hc392ba3urehimqr3gmq1a